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Abstract
Although inherited blood disorders are common among children in many parts of Africa, limited data are
available about their prevalence or contribution to childhood anaemia.We conducted a cross-sectional survey of
858 children aged 6–35 months who were randomly selected from 60 villages in western Kenya. Haemoglobin
(Hb), ferritin, malaria, C-reactive protein (CRP) and retinol binding protein (RBP) were measured from
capillary blood. Using polymerase chain reaction (PCR), Hb type, -3.7 kb alpha-globin chain deletion, glucose-
6-phosphate dehydrogenase (G6PD) genotype and haptoglobin (Hp) genotype were determined. More than 2
out of 3 children had at least one measured blood disorder. Sickle cell trait (HbAS) and disease (HbSS) were
found in 17.1% and 1.6% of children, respectively; 38.5% were heterozygotes and 9.6% were homozygotes for
a+-thalassaemia. The Hp 2-2 genotype was found in 20.4% of children, whereas 8.2% of males and 6.8% of
children overall had G6PD deficiency. There were no significant differences in the distribution of malaria by the
measured blood disorders, except among males with G6PD deficiency who had a lower prevalence of clinical
malaria than males of normal G6PD genotype (P = 0.005). After excluding children with malaria parasitaemia,
inflammation (CRP > 5 mg L-1), iron deficiency (ferritin < 12 mg L-1) or vitamin A deficiency (RBP < 0.7 mg L-1),
the prevalence of anaemia among those without a+-thalassaemia (43.0%) remained significantly lower than that
among children who were either heterozygotes (53.5%) or homozygotes (67.7%, P = 0.03). Inherited blood
disorders are common among pre-school children in western Kenya and are important contributors to anaemia.
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Introduction
Anaemia is a major cause of death and disease among
young children in Africa (WHO/UNICEF/UNU
2001). Previous studies in Kenya have found that
approximately 66% of children aged 6–35 months
were anaemic (Kenya Ministry of Health 2002; CDC
2007). Although iron deficiency is the most common
cause of anaemia, many other factors, including
malaria and other infections, vitamin A deficiency,
inflammation, and inherited blood disorders, play
variable roles in different settings (WHO/UNICEF/
UNU 2001).
Inherited blood disorders are common in sub-
Saharan Africa, such as a+-thalassaemia and the sickle
mutation of the b-globin gene (bs) that leads to the
production of HbS (Weatherall 2008). Every year, an
estimated 230 000 children are born in this region
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with sickle cell disease (SCD, HbSS), which is
approximately 85% of the global total (Modell &
Darlison 2008). In addition, haemoglobinopathies
contribute approximately 6.4% to the death rate of
children younger than 5 years in Africa (Modell &
Darlison 2008). Although detailed estimates of the
allele frequencies for both bs and a+-thalassemia are
available from the coast of Kenya (Williams et al.
2005b; Veenemans et al. 2008), few data are available
about the prevalence of these and other genetic dis-
orders in other parts of Kenya.
The current gene frequencies of haemoglobin
(Hb) and other blood disorders can be explained by
the survival advantage they provide against death
from Plasmodium falciparum malaria; natural selec-
tion has resulted in population frequencies that are
broadly proportional to the historic exposure to the
disease (Weatherall 2008). However, susceptibility to
malaria is likely affected by multiple host factors, and
the mechanisms for this protection are not com-
pletely understood. For example, although SCD may
be partially protective against infection with malaria,
affected children who do become infected are at sub-
stantial risk of subsequent death (Williams & Obaro
2011). In addition, a+-thalassaemia has also been
shown to ameliorate malaria risk (Wambua et al.
2006b), possibly by limiting the decline in Hb con-
centration that normally results from malaria infec-
tion (Mockenhaupt et al. 2004; Fowkes et al. 2008;
Veenemans et al. 2008). Glucose-6-phosphate dehy-
drogenase (G6PD) deficiency, also common in
Africa, may protect against malaria, although it can
also result in serious clinical outcomes caused by red
blood cell haemolysis (Guindo et al. 2007). Finally,
haptoglobin (Hp) binds free Hb following malaria-
induced haemolysis and, thus, serves an important
role in iron recycling, immune function and protec-
tion against oxidant stress (Gutteridge 1987). Poly-
morphisms in the Hp gene (e.g. Hp 2-2) have also
been associated with malaria protection (Atkinson
et al. 2007).
Limited data are available about the prevalence of
these multiple inherited blood disorders and their
relationships with anaemia and malaria among chil-
dren in Africa. In our study, we aimed to determine
the prevalence of the inherited blood disorders HbS,
a+-thalassaemia, G6PD deficiency and Hp 2-2 geno-
type in a cross-sectional sample of pre-school children
in western Kenya to learn more about their associa-
tions with anaemia and malaria.
Materials and methods
Participants
The study was conducted in Nyando Division, a
largely rural region within Nyanza Province in
western Kenya that includes approximately 80 000
people and 15 000 households. Most residents are
subsistence farmers and part of the Luo ethno-
linguistic group. Intense malaria transmission occurs
in this region throughout the year, peaking in the
rainy seasons. The study was part of a larger longitu-
dinal study, the Nyando Integrated Child Health and
Education Project (NICHE), which evaluated the
effectiveness of the promotion and sale of evidence-
based health products, including micronutrient
powders in 60 study villages during 2007–2010.
Details of NICHE are described elsewhere (CDC
2007; Suchdev et al. 2010; Suchdev et al. 2012).
Key messages
• More than 2 out of 3 pre-school children in western Kenya have one or more disorders: HbAS, HbSS,
a+-thalassaemia, G6PD deficiency or the Hp 2-2 genotype.
• a+-thalassaemia was strongly associated with anaemia with adjusted haemoglobin (Hb) concentrations
4–6 g L-1 lower in a+-thalassaemics compared with normal children.
• G6PD deficiency in males was associated with a lower prevalence of clinical malaria, and sickle cell trait was
protective against malaria-associated Hb decline.
• Programmes to combat anaemia and malaria should consider inherited blood disorders as part of an integrated
and multifactorial approach.
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Data and sample collection and processing
A cross-sectional survey was conducted in the 60
study villages during August 2010. Using an updated
household census, 19 compounds were randomly
selected per village. Lists of selected compounds were
provided to the field team, and all children aged 6–35
months living in these compounds were approached
for enrolment. Trained fieldworkers administered
questionnaires to the mothers of study participants to
collect data on demographic and socio-economic
factors, hygiene, sanitation, child feeding practices
and child morbidity during the preceding 24 h.
Anthropometric measurements were also made, and
capillary blood samples were collected for Hb meas-
urements and the preparation of malaria smears.Aliq-
uots were stored for the later measurement of
C-reactive protein (CRP), iron and vitamin A status,
and genotyping for blood disorders.
Details of the laboratory analyses are described in
detail elsewhere (Grant et al. 2012). Briefly, Hb levels
were measured in the field by using HemoCue® pho-
tometers (Angelholm, Sweden), and children were
classified as aanemic if their Hb was <110 g L-1
(McLean et al. 2009). Malaria blood slides were read
at the CDC laboratory in Kisian, Kenya. Parasite den-
sities were estimated from the ratio of parasites to
leukocytes, assuming a leukocyte count of 8000 mL-1.
Children with severe anaemia (i.e. Hb < 70 g L-1) or
with clinical malaria (fever with a positive malaria
smear) were referred for treatment to the nearest
hospital or clinic.
Frozen plasma samples were transported to a labo-
ratory in Germany (VitA-Iron Lab), where levels of
ferritin, retinol binding protein (RBP) and CRP were
measured by sandwich enzyme-linked immunosorb-
ent assay, as described in detail previously (Erhardt
et al. 2004). The following thresholds were used to
define abnormal values for these biochemical indica-
tors: ferritin <12 mg L-1; RBP <0.7 mmol L-1; and
CRP > 5 mg L-1 (Erhardt et al. 2004). Because ferritin
and RBP levels are influenced by the presence of
infection or inflammation, subjects with a CRP level
of >5 mg L-1 were excluded from estimates of iron or
vitamin A deficiency in the population (Thurnham
et al. 2003; WHO/CDC 2004). For the purposes of this
analysis, and in line with current WHO/CDC recom-
mendations, we used low ferritin as the indicator of
choice for iron deficiency (WHO/CDC 2004).
Packed red blood cells were transported at -20°C
to the KEMRI Centre for Geographic Medicine
Research in Kilifi for genetic diagnosis of the inher-
ited blood disorders. Genotyping for HbS, the
common African 3.7-kb a-globin a+-thalassaemia
deletion, and Hp were conducted by polymerase
chain reaction (PCR) as described in detail previously
(Chong et al. 2000; Waterfall & Cobb 2001; Williams
et al. 2005c; Atkinson et al. 2006). A child with one
a-globin deletion (-a/aa) was defined as hetero-
zygous a-thalassaemia, and a child with two a-globin
deletions (-a/-a) was defined as homozygous
a-thalassaemia. Typing for the common G6PD vari-
ants that are prevalent in the Kilifi population
(G6PDB, G6PDA and G6PDA-) was performed by
using a novel ARMS PCR method as follows. By
using SMS Primer2 software (Stothard 2000), we
designed two sets of allele-specific oligonucleotide
primers for the wild- and mutant-type SNPs at posi-
tions 202 (rs1050828) (WT202: TGCCCGAAAAC
ACCTTCATCG and MT202: TGCCCGAAAAC
ACCTTCATCA) and 376 (rs1050829) (WT376:
ACCCCAGGTGGAGGGCATT and MT 376: ACC
CCAGGTGGAGGGCATC). In all reactions, we
included two additional primers (Lis F and Lis R)
that target the Lis 1 gene (Chong et al. 2000) as a
positive control for the presence of genomic DNA.
We used the following PCR conditions: denaturation
at 95°C for 5 min; 30 cycles of 94°C (0:45 s), 65°C
(1:30 s) 72°C (2:00 s), and a final elongation step of
72°C for 7 min.We used three separate PCR reactions
to identify the three allelic forms of G6PD (B, A and
A-), the primer combination for each reaction being
as follows: G6PDB (WT202 and WT376), G6PDA
(MT376 and WT202) and G6PDA- (MT202 and
MT376). In all three reactions, the amplification of a
766 bp fragment in the presence of lis 1 gene amplicon
(2.1 kb) was considered as positive for the targeted
allele and negative when only the lis 1 gene amplicon
was present. On the basis of recent phenotypic studies
(S. Shah, unpublished observations), we classified
males as G6PD deficient if they were hemizygous for
the G6PDA- allele, and females as G6PD deficient if
Inherited blood disorders in western Kenya 137
© 2012 John Wiley & Sons Ltd Maternal and Child Nutrition (2014), 10, pp. 135–144
they were homozygous for the G6PDA- allele (A-/
A-), or compound heterozygous for the G6PDA- and
G6PDA alleles (Chong et al. 2000; Stothard 2000).
Analyses of the effects of G6PD deficiency and
malaria were stratified by sex, as malaria protection
has only been demonstrated in hemizygous males, not
females (Guindo et al. 2007). In addition, a sample of
capillary blood was spotted onto filter paper strips
and transported at ambient temperatures to CDC
Atlanta for Hb analysis with isoelectric focusing
(IEF) by using the Resolve® Hemoglobin Kit (Perkin
Elmer, Turku, Finland), according to the manufactur-
er’s protocol. Phenotypes of the samples were based
on the migration of the Hb and comparison with con-
trols for HbA, HbS, HbC and HbD (Analytical
Control Systems, Inc., Fishers, IN, USA). HbS status
by IEF was used in the analysis for subjects with
insufficient blood volumes for PCR.
Data handling
Statistical analyses were conducted by using SPSS
(version 14, SPSS Inc., Chicago, IL, USA), accounting
for cluster sampling.We used the WHO Child Growth
Standards (WHO Anthro, Geneva, Switzerland) to
calculate z-scores, and we categorised underweight as
a weight-for-age z-score of <-2, stunting as a height/
length-for-age z-score of <-2 and wasting as a weight-
for-height/length z-score of <-2. The means of
normally distributed data were compared by using
the Student’s t-test or analysis of variance. Categori-
cal variables were compared by using Pearson’s chi-
square or Fisher’s exact tests, as indicated. We
assessed the effect of malaria infection on Hb concen-
trations by blood disorder genotype in a multivariate
linear regression model, accounting for cluster sam-
pling that adjusted for age, height-for-age z-score, fer-
ritin and RBP. In this model, we evaluated whether
the effect of malaria depended on blood disorder
genotype by examining interaction terms (i.e. geno-
type times malaria status). We did not adjust for the
presence of inflammation because the effect of infec-
tion on Hb concentration may be mediated, at least in
part through inflammation. P-values < 0.05 were con-
sidered significant.
Ethical considerations
The study was approved by the Kenya Medical
Research Institute National Ethical Review Commit-
tee and by the institutional review board of the US
Centers for Disease Control and Prevention. Written
informed consent was obtained from the parents or
caregivers of all subjects. This trial is registered at
clinicaltrials.gov, identifier NCT01088958.
Results
A total of 1348 children were assessed for eligibility,
and 882 were enrolled. Of the 466 children not
enrolled, 57.7% were outside the age range, 26.6%
were not encountered on three attempted household
visits, parental consent was not obtained in 7.1%, and
8.6% were not enrolled for other reasons. An addi-
tional 24 children were excluded because of missing
Hb data, which led to 858 children included in the
final analysis. Characteristics of the study population
are shown in Table 1. The mean age of children was
21.5 months; 50.3% were male and approximately
75% were anaemic. Iron deficiency, vitamin A defi-
ciency and malaria parasitaemia were detected in
27.2%, 16.8% and 32.5% of children, respectively.
Prevalence of inherited blood disorders
Sufficient sample was available for genotyping for
99.5% (854/858) of the children included in our final
analysis. The prevalence of inherited blood disorders
among these children is summarised in Table 2.At the
HBB locus, 81.3% were of normal genotype (HbAA),
17.1% had sickle cell trait (HbAS) and 1.6% had
SCD (HbSS). A total of 51.9% of subjects were of
normal a+-thalassaemia genotype (aa/aa), 38.5%
were heterozygotes (-a/aa) and 9.6% were homozy-
gotes (-a/-a). Hp 2-2 genotype and G6PD deficiency
were found in 20.4% and 6.8% of children, respec-
tively. There were no significant differences in the
prevalence of the inherited blood disorders by sex,
including G6PD deficiency (8.2% in males and 5.4%
in females, P = 0.12). The mean age of children with
HbSS was 15.8 months, compared with 22.4 and 21.4
months for those with HbAS and HbAA, respectively
P.S. Suchdev et al.138
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(P = 0.015). Overall, 70.1% of the 809 children for
whom data were available for all four conditions –
HbS, a+-thalassaemia, G6PD deficiency and Hp 2-2 –
were positive for one or more of these conditions.
Associations with malaria and anaemia
There were no significant differences in the distribu-
tion of malaria by the measured blood disorders,
except for G6PD among males for whom clinical
malaria was significantly less common among those
with G6PD deficiency than those of normal genotype
(P = 0.005) (Table 3). There was no effect of G6PD
deficiency on malaria in females (data not shown).
There were no differences in mean parasite densities
by the measured blood disorders.
The a+-thalassaemia was associated with a signifi-
cantly increased prevalence of anaemia (82.3% in
homozygotes, 75.4% in heterozygotes and 66.7% in
normal;P = 0.005). Children with HbSS, however, had
a similar prevalence of anaemia as those with HbAA
(71.4% vs. 72.2%), even among those <24 months of
age (70.0% vs. 75.2%). No association was found
between Hp 2-2 or G6PD deficiency and the preva-
lence of anaemia (data not shown). Children with any
one of the four measured blood disorders were 1.45
times more likely to be anaemic compared with those
without a blood disorder (95% CI = 1.01–2.09).
To assess the residual anaemia associated with the
blood disorders, we excluded 563 children with either
malaria, inflammation (CRP > 5 mg L-1), iron defi-
ciency or vitamin A deficiency. There remained a sig-
nificant difference in anaemia among those with
normal a+-thalassaemia genotype (43.0%), heterozy-
gotes (53.5%) and homozygotes (67.7%, chi-square
trend P = 0.012) (Table 4). We found no significant
differences in anaemia by genotype for SCD, G6PD
deficiency or Hp 2-2 (data not shown).
In a multivariate analysis, the drop in Hb concen-
tration adjusting for confounders was compared
according to inherited blood disorder (Table 5). Chil-
dren heterozygous or homozygous for a-thalassaemia
had a lower Hb than those with normal genotype,
Table 1. Characteristics of enrolled children aged 6–35 months in
western Kenya, 2010
N = 858 N % or mean (95% CI)
Male sex, % 432 50.3 (46.9–53.8)
Age (months), mean 858 21.5 (20.9–22.1)
Ever breastfed, % 761 91.1 (88.1–94.2)
Currently breastfeeding, % 418 54.1 (50.2–57.9)
ITN use, % 765 92.3 (90.6–94.8)
Fever in last 24 h, % 232 27.1 (23.3–30.9)
Hb (g per L), mean 858 96.4 (95.1–98.2)
Anaemia (Hb<110 g L-1), % 614 71.6 (68.1–75.1)
Iron deficiency
(ferritin < 12 mg L-1) %
162 19.1 (16.0–22.7)
Iron deficiency*
(ferritin < 12 mg L-1), %
152 27.2 (23.0–31.5)
Vitamin A deficiency
(RBP < 0.7 mg L-1), %
262 30.9 (27.2–35.0)
Vitamin A deficiency*
(RBP < 0.7 mg L-1), %
94 16.8 (13.4–20.3)
Malaria positive, % 276 32.5 (28.5–36.7)
Malaria positive and
self-reported fever, %
122 14.4 (12.0–17.2)
Elevated CRP (>5 mg L-1), % 289 34.1 (29.8–38.7)
Stunted (HAZ < -2), % 252 29.5 (26.4–32.7)
Wasted (WHZ < -2), % 30 3.5 (1.9–5.1)
Underweight (WAZ < -2), % 103 12.0 (9.7–14.4)
ITN, insecticide-treated nets; Hb, haemoglobin; CRP, C-reactive
protein; WAZ, weight-for-age z-score; HAZ, height-for-age z-score;
WHZ, weight-for-height z score. Data are presented as percentage or
mean (95% confidence interval). *Restricted to n = 558 children with
CRP  5 mg L-1.
Table 2. Prevalence of sickle cell haemoglobin and a+-thalassaemia,
haptoglobin and G6PD genotypes among children aged 6–35 months
in western Kenya, 2010
Overall Males Females
Haemoglobin type (n = 854)
HbAA 694 (81.3) 351 (81.6) 343 (80.9)
HbAS 146 (17.1) 69 (16.0) 77 (18.2)
HbSS 14 (1.6) 10 (2.3) 4 (0.5)
a+-thalassaemia genotype (n = 823)
Normal (aa/aa) 427 (51.9) 210 (50.7) 217 (50.8)
Heterozygote (-a/aa) 317 (38.5) 164 (39.6) 153 (37.4)
Homozygote (-a/-a) 79 (9.6) 40 (9.7) 39 (9.5)
Haptoglobin genotype (n = 802)
Hp 1-1 251 (31.3) 127 (31.6) 124 (31.0)
Hp 1–2 387 (48.3) 189 (47.0) 198 (49.5)
Hp 2-2 164 (20.4) 86 (21.4) 78 (19.5)
G6PD genotype (n = 826)
Normal 770 (93.2) 381 (91.8) 389 (94.6)
Deficient 56 (6.8) 34 (8.2) 22 (5.4)
HbAA, normal genotype; HbAS, sickle cell trait; HbSS, sickle cell
disease; Hp, haptoglobin; G6PD, glucose-6-phosphate dehydroge-
nase. Data are shown as number of cases (%) by sex.
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although this observation did not reach statistical sig-
nificance (P = 0.058). Hp 2-2 was associated with a
lower Hb compared with those with Hp 1–2 or 1–2
genotype (P = 0.018).There were no significant differ-
ences in the drop in Hb that was associated with
malaria parasitaemia, except in the case of HbS,
where parasitaemia was associated with a drop of
2.5 g L-1 among children with sickle cell trait com-
pared with 12 g L-1 among those with HbAA (P for
interaction = 0.014) (Table 6).
Discussion
In common with reports from other parts of Kenya,
we found a high prevalence of inherited blood disor-
ders among pre-school children in Nyando Division,
western Kenya, where more than 2 out of 3 children
have one or more of the disorders HbAS, HbSS,
a+-thalassaemia, G6PD deficiency or the Hp 2-2 geno-
type. Most notably,a+-thalassaemia was strongly asso-
ciated with anaemia, and after eliminating other
known causes of anaemia, such as iron and vitamin A
deficiencies, malaria and inflammation, Hb concentra-
tions were 4–6 g L-1 lower in a+-thalassaemics than in
normal children.
To our knowledge, this is the first published study in
which the prevalence of multiple blood disorders has
been described in a single population within western
Kenya. In keeping with previous reports from the
Asembo Bay area of western Kenya (Aidoo et al.
2002; Desai et al. 2005), we found that the prevalence
of HbAS (17.1%) appeared to be slightly higher
than that described in coastal populations (15%)
(Scott et al. 2011). However, the prevalence of
a+-thalassaemia was lower than that among coastal
Table 3. Distribution of malaria among children aged 6–35 months in western Kenya according to HbS, a+-thalassaemia, haptoglobin type and
G6PD genotype, 2010
Positive malaria Clinical malaria* Parasite density‡
Haemoglobin type
HbAA 222 (32.2) 97 (14.0) 3.5
HbAS 50 (34.2) 21 (14.4) 3.6
HbSS 4 (30.8) 4 (28.6) 3.0
P-value 0.89 0.31 0.38
a+-thalassaemia genotype
Normal (aa/aa) 137 (32.3) 68 (16.1) 3.5
Heterozygote (-a/aa) 110 (34.9) 42 (13.4) 3.6
Homozygote (-a/-a) 19 (24.4) 7 (9.0) 3.5
P-value 0.20 0.21 0.68
Haptoglobin genotype
Hp 1-1 or Hp 1–2 203 (32.0) 92 (14.6) 3.5
Hp 2-2 53 (32.9) 20 (12.4) 3.6
P-value 0.85 0.49 0.45
G6PD genotype†
Normal 125 (33.0) 64 (16.9) 3.5
Deficient 8 (23.5) 0 (0.0) 3.4
P-value 0.25 0.005 0.60
Data are shown as number of cases (%) by malaria status. Differences in proportions using chi-square test. *Positive malaria smear and reported
fever in last 24 h. †G6PD cases restricted to males. ‡Mean of log10-transformed parasitaemia per mL of whole blood.
Table 4. Residual anaemia among children aged 6–35 months in
western Kenya as explained by a+-thalassaemia, 2010
Normal
(aa/aa)
Heterozygote
(-a/aa)
Homozygote
(-a/-a)
P
% Anemic 43.0 53.5 67.7 0.012
Mean Hb
(g per L)
109.3 103.1 105.3 0.018
CRP, C-reactive protein; RBP, retinol binding protein. Data represent
n = 260 children where no malaria, no inflammation
(CRP  5 mg L-1), normal iron status (ferritin  12 mg L-1) and no
vitamin A deficiency (RBP  0.7 mmol L-1). Proportion data com-
pared by using chi-square for trend, and means compared by using
ANOVA.
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populations where the prevalence of heterozygous
and homozygous a+-thalassaemia has been estimated
at 39–53% and 15–17%, respectively (Wambua et al.
2006b; Veenemans et al. 2008). This observation is
interesting because, like HbAS, a+-thalassaemia
might also be expected to be higher in Nyanza prov-
ince than on the coast, given greater selection pres-
sure from malaria. Although we can speculate that
this might be explained by negative co-evolution of
these two conditions, as suggested by several recent
studies (Williams et al. 2005b; May et al. 2007; Penman
et al. 2009), further studies will be required in multiple
populations to examine this question in more detail.
Given the high mortality that is traditionally asso-
ciated with undiagnosed SCD in sub-Saharan Africa
(Grosse et al. 2011), we were surprised by the high
prevalence of HbSS (1.6%) found among our study
population, a prevalence close to that reported at
birth in previous studies among a nearby population
(Aidoo et al. 2002). Because there is no active pro-
gramme of diagnosis or treatment for SCD, we had
anticipated that survivorship would have been lower.
The observed number of survivors might potentially
be explained by the young age of our sampled popu-
lation or by the improved nutrition and hygiene meas-
ures introduced through the NICHE study (Suchdev
et al. 2012).
In agreement with previous studies (Williams et al.
2005a; Wambua et al. 2006b), we found no evidence
for a protective effect of either HbAS or
Table 5. Mean adjusted haemoglobin concentration among children aged 6–35 months in western Kenya according to a+-thalassaemia, HbS,
haptoglobin and G6PD genotype, 2010
N Adjusted mean Hb (95% CI) P*
Normal 427 96.1 (94.7–98.1) 0.058
a+-thalassaemia hetero/homo 396 92.9 (90.8–95.1)
HbAA 694 94.4 (93.0–95.8) 0.409
HbAS 146 95.8 (92.5–99.0)
Hp1-1/Hp1–2 638 95.2 (93.7–96.7) 0.018
Hp 2-2 164 92.2 (90.2–94.3)
Normal 381 92.5 (90.5–94.4) 0.212
G6PD deficient† 34 95.3 (90.7–99.9)
Data are presented as adjusted mean Hb in g per L (95% CI). *Effect of blood disorder on haemoglobin by using multiple linear regression
adjusting for age, height-for-age z-score, malaria, ferritin and retinol binding protein, accounting for cluster sampling. †G6PD cases restricted to
males.
Table 6. Haemoglobin concentration among children aged 6–35 months in western Kenya according to a+-thalassaemia, HbS, haptoglobin and
G6PD genotype by malaria positivity, 2010
n (-) Malaria N (+) Malaria Change in Hb (g per L) P*
Mean Hb Mean Hb
Normal 287 101.5 (98.9–104.1) 137 90.2 (86.8–93.5) -11.3 0.241
a+-thalassaemia hetero/homo 264 97.5 (94.6–100.5) 129 88.9 (86.0–91.8) -8.6
HbAA 467 100.1 (98.1–102.0) 222 88.1 (85.6–90.5) -12.0 0.014
HbAS 96 98.2 (93.8–102.7) 50 95.7 (90.4–101.0) -2.5
Hp1-1/Hp1–2 632 100.4 (98.1–102.7) 203 90.1 (87.5–92.8) -10.3 0.580
Hp 2-2 108 97.9 (95.1–100.8) 53 86.2 (82.1–90.2) -11.7
Normal 254 97.4 (94.3–100.4) 125 87.6 (84.1–91.1) -9.8 0.212
G6PD deficient† 26 100.6 (95.3–105.9) 8 89.2 (78.5–100.0) -11.4
Data are presented as adjusted mean Hb in g per L (95% CI). *Interaction P-value for models by using multiple linear regression, adjusting for
age, height-for-age z-score, malaria, ferritin and retinol binding protein, accounting for cluster sampling. †G6PD cases restricted to males.
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a+-thalassaemia against the prevalence of either
symptomless malaria parasitaemia or clinical malaria
infection (Table 3). Although previous studies have
shown that a+-thalassaemia protects against the
decline in Hb concentration associated with malaria
infection (Wambua et al. 2006b; May et al. 2007), we
did not observe this effect (Table 6). However, our
data did show a protective effect of sickle cell trait
(HbAS) against malaria-associated Hb decline, which
may be a mechanism to explain the lower risk of
malaria-specific mortality in subjects with HbAS
compared with HbAA (Williams & Obaro 2011).
Compared with Hp 1-1 or Hp 1–2, we found that
the Hp 2-2 genotype was associated with a signifi-
cantly higher drop in Hb concentration among this
malaria-endemic setting, an observation that accords
with that made by Atkinson and colleagues in a
cohort study conducted in The Gambia (Atkinson
et al. 2006). Because Hp 2-2 binds less efficiently to
Hb, it may be less efficient at scavenging free Hb iron
following malaria-induced haemolysis (Okazaki &
Nagai 1997).
Our study has a number of limitations. First, it is
possible that other inherited blood disorders might be
present among the population for which we did not
measure. For example, we did not test for
b-thalassaemia because previous studies from the
region have not found evidence of this condition
(Wambua et al. 2006a); nevertheless, there are no
reports that exclude the possibility that this condition
might be prevalent in this part of Kenya. Second, this
study was cross-sectional, so it is not possible to evalu-
ate the effects of the inherited blood disorders on
malaria or anaemia risk. Finally, data are representa-
tive of a single division in Kenya and are not repre-
sentative of Kenya as a whole.As in other countries in
Africa, it is likely that ethnic diversity will have a
major effect on the prevalence of inherited blood dis-
orders in Kenya, which need to be further evaluated
in large population-based surveys.
In conclusion, inherited blood disorders, including
SCD, a+-thalassaemia, G6PD deficiency and the Hp
2-2 genotype, are common among pre-school children
in western Kenya and have mixed associations with
anaemia and malaria. Further studies are needed to
measure and classify these blood disorders in
resource-poor countries and to understand further
the mechanisms through which they associate with
malaria and anaemia. Despite the general lack of
information on the global burden of inherited blood
disorders, progress is being made to establish popula-
tion screening and education programmes (Odame
2010). Programmes to combat anaemia and malaria
should consider inherited blood disorders as part of
an integrated and multifactorial approach.
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